Physician profile
Juan Grau
NPI 1992797542
$6,679.72
in general payments reported to CMS, 2019-2025
13 companies · $1,662 in 2025
The $1,662 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,720 · 2022: $1,445 · 2023: $1,111 · 2024: $742 · 2025: $1,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,514.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,205.48 | 2021-2025 | Sapien 3 Ultra Resilia, Konect Resilia |
| Abiomed | $1,271.03 | 2021-2025 | Impella |
| Medtronic, INC. | $1,062.65 | 2021-2025 | Penditure, Simulus, Corevalve Evolut R |
| Atricure, INC. | $843.95 | 2021-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Abbott Laboratories | $450.08 | 2021-2024 | Epic, Thoratec Heartmate 3 Lvas Implant Kit |
| Medistim USA, INC. | $323.10 | 2022 | |
| Haemonetics Corporation | $134.33 | 2025 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $102.90 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $78.27 | 2021 | |
| Lsi Solutions INC | $69.65 | 2025 | Cor-Knot |
| Bolton Medical INC | $65.05 | 2021 | |
| Davol INC. | $49.32 | 2025 | Channel Drain |
| E.R. Squibb & Sons, L.L.C. | $23.91 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Grau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.